Allison Elizabeth Hamilos

Allison Elizabeth Hamilos

Auto-generated profile, based on publicly available information

Allison Elizabeth Hamilos

Department of Neurobiology, Harvard Medical School

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2016 in Clinical Neurophysiology
Verified
Journal Article
Open access
OAOluwaseun Akeju
Oluwaseun Akeju
ASAndrew H. Song
Andrew H. Song
AHAllison E. Hamilos
Allison E. Hamilos
KPKara J. Pavone
Kara J. Pavone
FFFrancisco J. Flores
Francisco J. Flores
PPPatrick L. Purdon
Patrick L. Purdon
Ketamine is an N-methyl-d-aspartate (NMDA) receptor antagonist commonly administered as a general anesthetic. However, neural circuit mechanisms to explain ketamine anesthesia-induced unconsciousness in humans are yet to be clearly defined. Disruption of frontal-parietal network connectivity has been proposed as a mechanism to explain this brain state. However, this mechanism was recently demonstrated at subanesthetic doses of ketamine in awake-patients. Therefore, we investigated whether there is an electroencephalogram (EEG) signature specific for ketamine anesthesia-induced unconsciousness. We retrospectively studied the EEG in 12 patients who received ketamine for the induction of general anesthesia. We analyzed the EEG dynamics using power spectral and coherence methods. Following the administration of a bolus dose of ketamine to induce unconsciousness, we observed a "gamma burst" EEG pattern that consisted of alternating slow-delta (0.1-4Hz) and gamma (∼27-40Hz) oscillations. This pattern was also associated with increased theta oscillations (∼4-8Hz) and decreased alpha/beta oscillations (∼10-24Hz). Ketamine anesthesia-induced unconsciousness is associated with a gamma burst EEG pattern. The EEG signature of ketamine anesthesia-induced unconsciousness may offer new insights into NMDA circuit mechanisms for unconsciousness.

12 March 2015 in The EMBO Journal
Verified
Journal Article
Open access
PDF file
ZTZhixiang Tong
Zhixiang Tong
ASAniruddh Solanki
Aniruddh Solanki
AHAllison Hamilos
Allison Hamilos
OLOren Levy
Oren Levy
KWKendall Wen
Kendall Wen
JKJeffrey M Karp
Jeffrey M Karp
Derived from any somatic cell type and possessing unlimited self‐renewal and differentiation potential, induced pluripotent stem cells (iPSCs) are poised to revolutionize stem cell biology and regenerative medicine research, bringing unprecedented opportunities for treating debilitating human diseases. To overcome the limitations associated with safety, efficiency, and scalability of traditional iPSC derivation, expansion, and differentiation protocols, biomaterials have recently been considered. Beyond addressing these limitations, the integration of biomaterials with existing iPSC culture platforms could offer additional opportunities to better probe the biology and control the behavior of iPSCs or their progeny in vitro and in vivo . Herein, we discuss the impact of biomaterials on the iPSC field, from derivation to tissue regeneration and modeling. Although still exploratory, we envision the emerging combination of biomaterials and iPSCs will be critical in the successful application of iPSCs and their progeny for research and clinical translation.

23 December 2021 in eLife
Verified
Journal Article
Open access
AHAllison E Hamilos
Allison E Hamilos
GSGiulia Spedicato
Giulia Spedicato
YHYe Hong
Ye Hong
FSFangmiao Sun
Fangmiao Sun
YLYulong Li
Yulong Li
JAJohn A Assad
John A Assad
Clues from human movement disorders have long suggested that the neurotransmitter dopamine plays a role in motor control, but how the endogenous dopaminergic system influences movement is unknown. Here, we examined the relationship between dopaminergic signaling and the timing of reward-related movements in mice. Animals were trained to initiate licking after a self-timed interval following a start-timing cue; reward was delivered in response to movements initiated after a criterion time. The movement time was variable from trial-to-trial, as expected from previous studies. Surprisingly, dopaminergic signals ramped-up over seconds between the start-timing cue and the self-timed movement, with variable dynamics that predicted the movement/reward time on single trials. Steeply rising signals preceded early lick-initiation, whereas slowly rising signals preceded later initiation. Higher baseline signals also predicted earlier self-timed movements. Optogenetic activation of dopamine neurons during self-timing did not trigger immediate movements, but rather caused systematic early-shifting of movement initiation, whereas inhibition caused late-shifting, as if modulating the probability of movement. Consistent with this view, the dynamics of the endogenous dopaminergic signals quantitatively predicted the moment-by-moment probability of movement initiation on single trials. We propose that ramping dopaminergic signals, likely encoding dynamic reward expectation, can modulate the decision of when to move.

9 September 2021 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
KYKisuk Yang
Kisuk Yang
EOEoin O'Cearbhaill
Eoin O'Cearbhaill
SLSophie S. Liu
Sophie S. Liu
AZAngela Zhou
Angela Zhou
GCGirish D. Chitnis
Girish D. Chitnis
JKJeffrey M. Karp
Jeffrey M. Karp
Significance: Type 1 diabetes (T1D) is characterized by the autoimmune destruction of pancreatic β cells and it burdens millions worldwide. T1D patients typically require the life-long administration of insulin or immunosuppressive agents following transplantation. A macroencapsulation device (MED) acts as a bioartificial pancreas and can immunoprotect encapsulated β cells. However, conventional MEDs suffer from limited, cell-loading capacity and slow, glucose-stimulated insulin secretion (GSIS) because of the sole reliance on diffusion. Here, we developed a convection-enhanced MED (ceMED) to afford 3D capsule geometry for maximized cell loading and faster GSIS driven by convection. Overall, we demonstrated that the ceMED significantly improves nutrient exchange that enhances cell viability and GSIS, ultimately leading to a rapid reduction of hyperglycemia.

1 June 2016 in Clinical Neurophysiology
Verified
Journal Article
Open access
OAOluwaseun Akeju
Oluwaseun Akeju
AHAllison E. Hamilos
Allison E. Hamilos
ASAndrew H. Song
Andrew H. Song
KPKara J. Pavone
Kara J. Pavone
PPPatrick L. Purdon
Patrick L. Purdon
EBEmery N. Brown
Emery N. Brown
An emerging paradigm for understanding how anesthetics induce altered arousal is relating receptor targeting in specific neural circuits to electroencephalogram (EEG) activity. Enhanced gamma amino-butyric acid A (GABAA) inhibitory post-synaptic currents (IPSCs) manifest with large-amplitude slow (0.1-1Hz) and frontally coherent alpha (8-12Hz) EEG oscillations during general anesthesia. Therefore, we investigated the EEG signatures of modern day derivatives of ether (MDDE) anesthesia to assess the extent to which we could obtain insights into MDDE anesthetic mechanisms. We retrospectively studied cases from our database in which patients received isoflurane anesthesia vs. isoflurane/ketamine anesthesia (n=10 each) or desflurane anesthesia vs. desflurane/ketamine anesthesia (n=9 each). We analyzed the EEG recordings with spectral power and coherence methods. Similar to known GABAA circuit level mechanisms, we found that MDDE anesthesia induced large amplitude slow and frontally coherent alpha oscillations. Additionally, MDDE anesthesia also induced frontally coherent theta (4-8Hz) oscillations. Reduction of GABAergic IPSCs with ketamine resulted in beta/gamma (13-40Hz) oscillations, and significantly reduced MDDE anesthesia-induced slow, theta and alpha oscillation power. Large amplitude slow oscillations and coherent alpha and theta oscillations are moderated by ketamine during MDDE anesthesia. These observations are consistent with the notion that GABAA circuit-level mechanisms are associated with MDDE anesthesia-induced unconsciousness.

1 October 2022 in Behavioral Neuroscience
Verified
Journal Article
Closed access
AJAnthony M. V. Jakob
Anthony M. V. Jakob
JMJohn G. Mikhael
John G. Mikhael
AHAllison E. Hamilos
Allison E. Hamilos
JAJohn A. Assad
John A. Assad
SGSamuel J. Gershman
Samuel J. Gershman
The role of dopamine (DA) as a reward prediction error (RPE) signal in reinforcement learning (RL) tasks has been well-established over the past decades. Recent work has shown that the RPE interpretation can also account for the effects of DA on interval timing by controlling the speed of subjective time. According to this theory, the timing of the dopamine signal relative to reward delivery dictates whether subjective time speeds up or slows down: Early DA signals speed up subjective time and late signals slow it down. To test this bidirectional prediction, we reanalyzed measurements of dopaminergic neurons in the substantia nigra pars compacta of mice performing a self-timed movement task. Using the slope of ramping dopamine activity as a readout of subjective time speed, we found that trial-by-trial changes in the slope could be predicted from the timing of dopamine activity on the previous trial. This result provides a key piece of evidence supporting a unified computational theory of RL and interval timing. (PsycInfo Database Record (c) 2022 APA, all rights reserved).